SERTACONAZOLE NITRATE

SERTACONAZOLE NITRATE was reported 162 times

SERTACONAZOLE NITRATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BRONCHIAL STENT INSERTION 1 0.3333
1 VOCAL CORD AUGMENTATION 2 0.2500
2 EXPOSURE KERATITIS 6 0.2000
3 URETHRAL VALVES 14 0.1505
4 MENINGIOMA SURGERY 5 0.0758
5 PROTEIN ALBUMIN RATIO INCREASED 1 0.0714
6 BRAIN STEM AUDITORY EVOKED RESPONSE ABNORMAL 2 0.0426
7 EAR, NOSE AND THROAT EXAMINATION ABNORMAL 2 0.0333
8 REACTION TO MEDICAL AGENT PRESERVATIVES 1 0.0294
9 UPPER MOTOR NEURONE LESION 6 0.0273
10 INTRACRANIAL CALCIFICATION 1 0.0270
11 PLATELET DISTRIBUTION WIDTH INCREASED 1 0.0196
12 CHARLES BONNET SYNDROME 2 0.0167
13 PUNCTURE SITE ERYTHEMA 1 0.0116
14 ANAL POLYP 1 0.0097
15 REFRACTORINESS TO PLATELET TRANSFUSION 1 0.0092
16 ANAL EROSION 1 0.0091
17 PREALBUMIN DECREASED 1 0.0083
18 ABDOMINAL WALL CYST 1 0.0082
19 MYCOPLASMA INFECTION 6 0.0077
20 SERRATIA BACTERAEMIA 1 0.0068
21 CYTOLOGY ABNORMAL 1 0.0067
22 VITAMIN A DECREASED 1 0.0065
23 FACIAL ASYMMETRY 6 0.0063
24 CONFUSIONAL AROUSAL 1 0.0062
25 BONE HYPERTROPHY 1 0.0062
26 CENTRAL SLEEP APNOEA SYNDROME 2 0.0062
27 HEMIANOPIA 6 0.0060
28 PNEUMONIA PARAINFLUENZAE VIRAL 1 0.0059
29 FEEDING TUBE USER 2 0.0055
30 STRESS AT WORK 6 0.0053
31 HAEMOGLOBIN URINE PRESENT 1 0.0049
32 VESTIBULAR DISORDER 6 0.0049
33 SHUNT INFECTION 1 0.0044
34 PREMENSTRUAL SYNDROME 6 0.0044
35 MYOGLOBIN URINE PRESENT 1 0.0041
36 CARBUNCLE 1 0.0035
37 PERCUTANEOUS CORONARY INTERVENTION 1 0.0035
38 TRACHEOSTOMY 5 0.0035
39 REGRESSIVE BEHAVIOUR 1 0.0034
40 VOCAL CORD PARALYSIS 6 0.0033
41 CREATININE URINE INCREASED 1 0.0033
42 GASTROSTOMY 5 0.0032
43 POST PROCEDURAL BILE LEAK 1 0.0032
44 VULVITIS 1 0.0030
45 OPTIC NEUROPATHY 6 0.0028
46 CEREBELLAR SYNDROME 6 0.0027
47 PERSISTENT DEPRESSIVE DISORDER 1 0.0025
48 THREATENED LABOUR 1 0.0023
49 NITRITE URINE PRESENT 1 0.0023
50 DEGENERATIVE BONE DISEASE 1 0.0023
51 NEUROSIS 1 0.0022
52 HYPOMENORRHOEA 6 0.0022
53 URINARY TRACT DISCOMFORT 1 0.0022
54 SARS-COV-2 ANTIBODY TEST NEGATIVE 1 0.0021
55 RETINAL VEIN OCCLUSION 6 0.0021
56 ABORTION 6 0.0021
57 APPLICATION SITE INFECTION 1 0.0020
58 DEAFNESS NEUROSENSORY 6 0.0018
59 CRYSTAL URINE PRESENT 1 0.0018
60 ENCEPHALOMALACIA 1 0.0018
61 BACTERIURIA 1 0.0018
62 ENGRAFTMENT SYNDROME 1 0.0017
63 PNEUMOCYSTIS JIROVECII INFECTION 2 0.0017
64 MEAN PLATELET VOLUME INCREASED 1 0.0017
65 DIAPHRAGMATIC HERNIA 1 0.0016
66 VAGINITIS BACTERIAL 1 0.0016
67 URINARY SEDIMENT PRESENT 1 0.0016
68 URINE LEUKOCYTE ESTERASE POSITIVE 1 0.0014
69 ATTENTION DEFICIT HYPERACTIVITY DISORDER 6 0.0014
70 INTRAOCULAR PRESSURE TEST ABNORMAL 1 0.0014
71 DERMATITIS DIAPER 1 0.0014
72 ALANINE AMINOTRANSFERASE DECREASED 1 0.0014
73 MICROALBUMINURIA 1 0.0013
74 DYSPAREUNIA 6 0.0013
75 ENDOMETRIOSIS 6 0.0013
76 HORMONE LEVEL ABNORMAL 6 0.0012
77 INFECTED BITE 1 0.0012
78 PHLEBITIS 6 0.0012
79 FOOD REFUSAL 1 0.0011
80 NYSTAGMUS 6 0.0011
81 ABNORMAL WITHDRAWAL BLEEDING 1 0.0011
82 INTERMENSTRUAL BLEEDING 6 0.0011
83 RED BLOOD CELLS URINE POSITIVE 1 0.0010
84 SUSPECTED PRODUCT CONTAMINATION 1 0.0010
85 POLYHYDRAMNIOS 1 0.0010
86 HYPERPROLACTINAEMIA 6 0.0009
87 PNEUMONIA STREPTOCOCCAL 1 0.0009
88 BILIRUBIN CONJUGATED INCREASED 2 0.0009
89 DISCOURAGEMENT 2 0.0009
90 ESCHERICHIA TEST POSITIVE 1 0.0008
91 VISUAL FIELD DEFECT 6 0.0008
92 INTRA-ABDOMINAL HAEMATOMA 1 0.0008
93 BLOOD UREA DECREASED 1 0.0008
94 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0008
95 NEUTROPHIL PERCENTAGE INCREASED 1 0.0008
96 TROPONIN T INCREASED 1 0.0008
97 BRONCHIAL SECRETION RETENTION 1 0.0008
98 VULVOVAGINAL CANDIDIASIS 1 0.0007
99 TENOSYNOVITIS 2 0.0007
100 MENSTRUAL DISORDER 6 0.0007
101 APPLICATION SITE INFLAMMATION 1 0.0007
102 FACIAL PARALYSIS 6 0.0007
103 SEBORRHOEIC KERATOSIS 1 0.0007
104 MOTOR DYSFUNCTION 7 0.0007
105 GRIP STRENGTH DECREASED 6 0.0007
106 PELVIC INFLAMMATORY DISEASE 1 0.0007
107 FUNGAEMIA 1 0.0006
108 OPHTHALMOPLEGIA 1 0.0006
109 TINEA PEDIS 1 0.0006
110 SHOULDER FRACTURE 1 0.0006
111 SPINAL CORD DISORDER 1 0.0006
112 PAPILLOMA VIRAL INFECTION 1 0.0006
113 QUADRIPARESIS 1 0.0006
114 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 1 0.0006
115 BREAST PAIN 6 0.0006
116 NERVE INJURY 6 0.0005
117 MALNUTRITION 6 0.0005
118 WHITE BLOOD CELLS URINE POSITIVE 1 0.0005
119 HYPERTHERMIA 4 0.0005
120 CONVERSION DISORDER 1 0.0005
121 POLYCYTHAEMIA 1 0.0005
122 INFUSION SITE BRUISING 1 0.0005
123 OESOPHAGEAL VARICES HAEMORRHAGE 1 0.0005
124 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 1 0.0005
125 BACTERIAL TEST POSITIVE 1 0.0004
126 MENINGIOMA 7 0.0004
127 TACHYPNOEA 6 0.0004
128 KOUNIS SYNDROME 1 0.0004
129 THERMAL BURN 3 0.0004
130 PARALYSIS 6 0.0004
131 HUMERUS FRACTURE 2 0.0004
132 ANOSMIA 6 0.0004
133 SELF ESTEEM DECREASED 1 0.0004
134 DERMAL CYST 1 0.0004
135 MEAN CELL VOLUME INCREASED 1 0.0004
136 AORTIC ARTERIOSCLEROSIS 1 0.0004
137 PSYCHOMOTOR SKILLS IMPAIRED 1 0.0004
138 SHOULDER ARTHROPLASTY 1 0.0004
139 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0004
140 SCAR 6 0.0004
141 TASTE DISORDER 7 0.0003
142 AMENORRHOEA 6 0.0003
143 DECREASED INTEREST 2 0.0003
144 MYELOFIBROSIS 1 0.0003
145 EATING DISORDER 7 0.0003
146 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
147 ILEUS 4 0.0003
148 GLAUCOMA 6 0.0003
149 LIVER ABSCESS 1 0.0003
150 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0003
151 LISTLESS 1 0.0003
152 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
153 PEPTIC ULCER 1 0.0003
154 AGEUSIA 7 0.0003
155 HYPOALBUMINAEMIA 2 0.0003
156 PREGNANCY 5 0.0002
157 BLEPHARITIS 1 0.0002
158 FUNGAL SKIN INFECTION 1 0.0002
159 GENERALISED OEDEMA 3 0.0002
160 EUGLYCAEMIC DIABETIC KETOACIDOSIS 1 0.0002
161 SOCIAL PROBLEM 1 0.0002
162 PSYCHOLOGICAL TRAUMA 2 0.0002
163 DEAFNESS 6 0.0002
164 BEDRIDDEN 3 0.0002
165 GINGIVAL SWELLING 1 0.0002
166 RASH MACULO-PAPULAR 5 0.0002
167 NERVOUS SYSTEM DISORDER 7 0.0002
168 HIDRADENITIS 2 0.0002
169 ISCHAEMIA 1 0.0002
170 VAGINAL INFECTION 1 0.0002
171 THROMBOTIC MICROANGIOPATHY 2 0.0002
172 VENOOCCLUSIVE LIVER DISEASE 1 0.0002
173 HYPERNATRAEMIA 1 0.0002
174 PROTEIN URINE PRESENT 1 0.0002
175 PERIORBITAL OEDEMA 1 0.0002
176 IMPAIRED WORK ABILITY 4 0.0002
177 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
178 ANAL ABSCESS 1 0.0002
179 HIP SURGERY 1 0.0002
180 HYDROCEPHALUS 1 0.0002
181 FAECALOMA 1 0.0002
182 DERMATITIS CONTACT 2 0.0002
183 URINE ODOUR ABNORMAL 1 0.0002
184 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
185 BACTERAEMIA 2 0.0002
186 HYPOACUSIS 7 0.0002
187 CARDIOMEGALY 2 0.0002
188 INFUSION SITE EXTRAVASATION 1 0.0002
189 LIVER DISORDER 7 0.0002
190 PROCTALGIA 1 0.0002
191 METASTASES TO CENTRAL NERVOUS SYSTEM 2 0.0002
192 MATERNAL EXPOSURE BEFORE PREGNANCY 1 0.0001
193 APHONIA 2 0.0001
194 IMPAIRED QUALITY OF LIFE 2 0.0001
195 GASTROENTERITIS 2 0.0001
196 HYPOPHOSPHATAEMIA 1 0.0001
197 CEREBRAL DISORDER 1 0.0001
198 PAROSMIA 1 0.0001
199 TINNITUS 6 0.0001
200 DISSOCIATION 1 0.0001
201 FURUNCLE 1 0.0001
202 POLYURIA 1 0.0001
203 SPINAL COMPRESSION FRACTURE 1 0.0001
204 BLOOD MAGNESIUM DECREASED 1 0.0001
205 SPEECH DISORDER 6 0.0001
206 BLOOD BILIRUBIN INCREASED 3 0.0001
207 UROSEPSIS 1 0.0001
208 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
209 PERSONALITY CHANGE 1 0.0001
210 ARTERIOSCLEROSIS 1 0.0001
211 ABORTION INDUCED 1 0.0001
212 ERUCTATION 2 0.0001
213 DYSPHONIA 6 0.0001
214 INFLAMMATORY BOWEL DISEASE 1 0.0001
215 EMBEDDED DEVICE 1 0.0001
216 IRRITABILITY 6 0.0001
217 EYELID PTOSIS 1 0.0001
218 SLUGGISHNESS 1 0.0001
219 NEUTROPHIL COUNT INCREASED 1 0.0001
220 EUPHORIC MOOD 1 0.0001
221 RIB FRACTURE 2 0.0001
222 EXPOSURE DURING PREGNANCY 6 0.0001
223 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
224 DYSGEUSIA 7 0.0001
225 AMNESIA 6 0.0001
226 INJECTION SITE NODULE 1 0.0001
227 GASTRIC HAEMORRHAGE 1 0.0001
228 ELECTROLYTE IMBALANCE 1 0.0001
229 EYELID OEDEMA 1 0.0001
230 SURGERY 5 0.0001
231 DYSPHAGIA 8 0.0001
232 ATAXIA 1 0.0001
233 NOCTURIA 1 0.0001
234 SCHIZOPHRENIA 1 0.0001
235 INJECTION SITE EXTRAVASATION 1 0.0001
236 TENDON RUPTURE 1 0.0001
237 BALANCE DISORDER 7 0.0001
238 SECRETION DISCHARGE 1 0.0001
239 DERMATITIS ALLERGIC 1 0.0001
240 MYDRIASIS 1 0.0001
241 DIPLOPIA 2 0.0001
242 SEDATION 2 0.0001
243 SARS-COV-2 TEST POSITIVE 1 0.0001
244 DYSMENORRHOEA 1 0.0001
245 THROMBOSIS 6 0.0001
246 JAUNDICE 2 0.0001
247 DRUG TOXICITY 1 0.0001
248 MENTAL STATUS CHANGES 2 0.0001
249 HYPOMAGNESAEMIA 1 0.0001
250 BURNING SENSATION 5 0.0001
251 SUBDURAL HAEMATOMA 1 0.0001
252 PARAESTHESIA ORAL 1 0.0001
253 INJECTION SITE HAEMATOMA 1 0.0001
254 APATHY 1 0.0001
255 DYSSTASIA 2 0.0001
256 ECONOMIC PROBLEM 1 0.0001
257 HYPOKALAEMIA 3 0.0001
258 DEVICE RELATED INFECTION 1 0.0001
259 TENDONITIS 1 0.0001
260 VISUAL IMPAIRMENT 8 0.0001
261 BLOOD CHOLESTEROL INCREASED 3 0.0001
262 DRUG-INDUCED LIVER INJURY 2 0.0001
263 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
264 PNEUMOTHORAX 1 0.0001
265 HALLUCINATION, AUDITORY 1 0.0001
266 MIGRAINE 6 0.0001
267 SENSORY DISTURBANCE 1 0.0001
268 MOVEMENT DISORDER 2 0.0001
269 CYTOMEGALOVIRUS INFECTION 1 0.0001
270 FUNGAL INFECTION 2 0.0001
271 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
272 HAEMATURIA 2 0.0001
273 INFLAMMATION 3 0.0001
274 PARANOIA 1 0.0001
275 HYPERKALAEMIA 2 0.0001
276 LYMPHOCYTE COUNT DECREASED 1 0.0001
277 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
278 TOOTHACHE 1 0.0001
279 RESPIRATORY FAILURE 4 0.0001
280 END STAGE RENAL DISEASE 1 0.0001
281 CONJUNCTIVITIS 1 0.0001
282 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
283 BLOOD SODIUM DECREASED 1 0.0001
284 HYPOCALCAEMIA 1 0.0001
285 GASTRIC ULCER 1 0.0001
286 GAIT DISTURBANCE 10 0.0001
287 CHOLESTASIS 1 0.0001
288 PRESCRIBED OVERDOSE 1 0.0001
289 EAR PAIN 1 0.0001
290 VISION BLURRED 7 0.0001
291 HAEMATOCRIT DECREASED 1 0.0001
292 SPINAL FRACTURE 1 0.0000
293 SUICIDE ATTEMPT 3 0.0000
294 PERITONITIS 1 0.0000
295 HALLUCINATION, VISUAL 1 0.0000
296 INTENTIONAL OVERDOSE 3 0.0000
297 LIVER FUNCTION TEST INCREASED 1 0.0000
298 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
299 SEPTIC SHOCK 2 0.0000
300 MENTAL DISORDER 2 0.0000
301 APPLICATION SITE PAIN 1 0.0000
302 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
303 PULMONARY OEDEMA 2 0.0000
304 CHROMATURIA 1 0.0000
305 ERYTHEMA 9 0.0000
306 NEPHROLITHIASIS 2 0.0000
307 SHOCK 1 0.0000
308 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
309 HYPERSENSITIVITY 8 0.0000
310 PRODUCTIVE COUGH 2 0.0000
311 LOCALISED INFECTION 1 0.0000
312 PNEUMONIA ASPIRATION 1 0.0000
313 HALLUCINATION 3 0.0000
314 ABDOMINAL PAIN LOWER 1 0.0000
315 CHRONIC KIDNEY DISEASE 3 0.0000
316 WEIGHT DECREASED 11 0.0000
317 FALL 13 0.0000
318 HAEMATOMA 1 0.0000
319 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
320 ANHEDONIA 1 0.0000
321 DEPRESSED MOOD 2 0.0000
322 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
323 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
324 ABNORMAL DREAMS 1 0.0000
325 HAEMOPTYSIS 1 0.0000
326 WEIGHT INCREASED 8 0.0000
327 PAIN IN JAW 1 0.0000
328 DEPRESSION 8 0.0000
329 INTENTIONAL DOSE OMISSION 1 0.0000
330 RED BLOOD CELL COUNT DECREASED 1 0.0000
331 HERPES ZOSTER 2 0.0000
332 LIVER FUNCTION TEST ABNORMAL 1 0.0000
333 MUSCULOSKELETAL STIFFNESS 3 0.0000
334 NASAL CONGESTION 2 0.0000
335 PSYCHOTIC DISORDER 1 0.0000
336 CATARACT 2 0.0000
337 HEPATIC FAILURE 1 0.0000
338 APHASIA 1 0.0000
339 LACRIMATION INCREASED 1 0.0000
340 STOMATITIS 2 0.0000
341 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
342 BONE DENSITY DECREASED 1 0.0000
343 HEAD INJURY 1 0.0000
344 LACTIC ACIDOSIS 1 0.0000
345 BLOOD CREATININE INCREASED 2 0.0000
346 CHOLELITHIASIS 1 0.0000
347 RENAL FAILURE 4 0.0000
348 VIRAL INFECTION 1 0.0000
349 URINARY RETENTION 1 0.0000
350 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
351 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
352 HEPATIC ENZYME INCREASED 2 0.0000
353 NIGHTMARE 1 0.0000
354 SLEEP DISORDER 2 0.0000
355 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
356 RASH 12 0.0000
357 HYPERGLYCAEMIA 1 0.0000
358 DYSURIA 1 0.0000
359 INJECTION SITE MASS 1 0.0000
360 SEPSIS 3 0.0000
361 ASTHENIA 10 0.0000
362 DYSARTHRIA 1 0.0000
363 DYSPNOEA EXERTIONAL 1 0.0000
364 INSOMNIA 7 0.0000
365 ACUTE KIDNEY INJURY 4 0.0000
366 HOSPITALISATION 4 0.0000
367 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
368 SOMNOLENCE 5 0.0000
369 DYSKINESIA 1 0.0000
370 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000
371 BLINDNESS 1 0.0000
372 POLLAKIURIA 1 0.0000
373 URINARY TRACT INFECTION 4 0.0000
374 PRURITUS 9 0.0000
375 DEVICE DISLOCATION 1 0.0000
376 ANGIOEDEMA 1 0.0000
377 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
378 SKIN IRRITATION 1 0.0000
379 SKIN DISCOLOURATION 1 0.0000
380 DECREASED APPETITE 5 0.0000
381 COGNITIVE DISORDER 1 0.0000
382 COUGH 6 0.0000
383 SWELLING 2 0.0000
384 ARRHYTHMIA 1 0.0000
385 PULMONARY EMBOLISM 2 0.0000
386 COMA 1 0.0000
387 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
388 HYPOGLYCAEMIA 1 0.0000
389 SYNCOPE 2 0.0000
390 HYPOTENSION 4 0.0000
391 CELLULITIS 1 0.0000
392 CONDITION AGGRAVATED 6 0.0000
393 CHEST DISCOMFORT 2 0.0000
394 FATIGUE 15 0.0000
395 ECZEMA 1 0.0000
396 DISTURBANCE IN ATTENTION 1 0.0000
397 RASH PRURITIC 1 0.0000
398 OEDEMA 1 0.0000
399 CONSTIPATION 4 0.0000
400 DIZZINESS 9 0.0000
401 BLISTER 1 0.0000
402 EYE PAIN 1 0.0000
403 ANXIETY 5 0.0000
404 OFF LABEL USE 15 0.0000
405 COVID-19 3 0.0000
406 DISEASE PROGRESSION 2 0.0000
407 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
408 JOINT SWELLING 2 0.0000
409 NO ADVERSE EVENT 3 0.0000
410 THERAPEUTIC RESPONSE DECREASED 1 0.0000
411 ILL-DEFINED DISORDER 1 0.0000
412 PLEURAL EFFUSION 1 0.0000
413 OEDEMA PERIPHERAL 2 0.0000
414 VERTIGO 1 0.0000
415 NASOPHARYNGITIS 3 0.0000
416 MALAISE 7 0.0000
417 LOSS OF CONSCIOUSNESS 2 0.0000
418 HYPERHIDROSIS 2 0.0000
419 PNEUMONIA 5 0.0000
420 DEHYDRATION 2 0.0000
421 INJECTION SITE PRURITUS 1 0.0000
422 VOMITING 7 0.0000
423 NEUTROPENIA 2 0.0000
424 DEVICE MALFUNCTION 1 0.0000
425 SKIN BURNING SENSATION 1 0.0000
426 AGITATION 1 0.0000
427 BRONCHITIS 1 0.0000
428 EPISTAXIS 1 0.0000
429 ACNE 1 0.0000
430 HEADACHE 8 0.0000
431 PARAESTHESIA 2 0.0000
432 NAUSEA 10 0.0000
433 INJECTION SITE HAEMORRHAGE 1 0.0000
434 FEELING ABNORMAL 3 0.0000
435 CARDIAC FAILURE CONGESTIVE 1 0.0000
436 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
437 CARDIAC ARREST 1 0.0000
438 ARTHRALGIA 5 0.0000
439 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
440 RENAL IMPAIRMENT 1 0.0000
441 MYALGIA 2 0.0000
442 PYREXIA 4 0.0000
443 MYOCARDIAL INFARCTION 2 0.0000
444 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
445 GASTROINTESTINAL DISORDER 1 0.0000
446 DEVICE ISSUE 1 0.0000
447 ADVERSE DRUG REACTION 1 0.0000
448 SUICIDAL IDEATION 1 0.0000
449 ADVERSE EVENT 1 0.0000
450 NEUROPATHY PERIPHERAL 1 0.0000
451 DYSPEPSIA 1 0.0000
452 FLUSHING 1 0.0000
453 SINUSITIS 1 0.0000
454 HAEMOGLOBIN DECREASED 1 0.0000
455 ILLNESS 1 0.0000
456 ABDOMINAL DISTENSION 1 0.0000
457 HAEMORRHAGE 1 0.0000
458 PLATELET COUNT DECREASED 1 0.0000
459 DIARRHOEA 6 0.0000
460 THROMBOCYTOPENIA 1 0.0000
461 DYSPNOEA 5 0.0000
462 RHEUMATOID ARTHRITIS 1 0.0000
463 SEIZURE 1 0.0000
464 ABDOMINAL PAIN 2 0.0000
465 EMOTIONAL DISTRESS 1 0.0000
466 PAIN 5 0.0000
467 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
468 PRODUCT QUALITY ISSUE 1 0.0000
469 PAIN IN EXTREMITY 2 0.0000
470 HYPOAESTHESIA 1 0.0000
471 BLOOD PRESSURE INCREASED 1 0.0000
472 DRUG INTERACTION 1 0.0000
473 CONFUSIONAL STATE 1 0.0000
474 URTICARIA 1 0.0000
475 MUSCLE SPASMS 1 0.0000
476 CHEST PAIN 1 0.0000
477 BLOOD GLUCOSE INCREASED 1 0.0000
478 ABDOMINAL PAIN UPPER 1 0.0000
479 INCORRECT DOSE ADMINISTERED 1 0.0000
480 PRODUCT DOSE OMISSION ISSUE 1 0.0000
481 DRUG INEFFECTIVE 2 0.0000
482 DEATH 1 0.0000